Medicare May Rethink Premium Hike for Pricey Alzheimer Drug
Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer disease drug Aduhelm.
January 10, 2022
by drugs
University of Glasgow reveals drug design for new Alzheimer’s treatments
A team of scientists and pharmaceutical collaborators have discovered a ‘bench to bedside’ drug design, which will hopefully improve the future treatment of Alzheimer’s disease...
December 1, 2021
by PharmaTimes
Dementia research that moves us forward: Alzheimer Society of Canada invests $3 million in dementia researchers across the country
The Alzheimer Society of Canada has announced an investment of more than three million dollars in funding, that will support 26 dementia researchers and their teams across Canada.
August 25, 2021
by firstwordpharma
Some Diabetes Meds Might Also Lower Alzheimer's Risk
Older adults who take certain diabetes drugs may see a slower decline in their memory and thinking skills, a new study suggests.
August 13, 2021
by drugs
Deaths From Alzheimer's Far More Common in Rural America
Death rates from Alzheimer's disease are particularly high in the rural United States, a preliminary study finds, highlighting a need for health care resources in traditionally under-served areas.
August 2, 2021
by drugs
Global Dementia Cases Projected to Top 152 Million in 2050
Global dementia cases are projected to increase to an estimated 152.8 million cases in 2050, according to a study presented at the annual Alzheimer's Association International Conference, held from July 26 to 30 in Denver.
July 30, 2021
by drugs
COVID-19 Associated With Long-Term Cognitive Dysfunction, Acceleration Of Alzheimer's Symptoms
Much has been learned about SARS-CoV-2, the virus that causes the novel coronavirus, since the beginning of the COVID-19 pandemic. However, questions remain about the long-term impact of the virus on our bodies and brains.
July 30, 2021
by firstwordpharma
1 in 20 Cases of Dementia Occurs in People Under 65
Dementia is largely a disease of old age, but a new study finds that up to 5% of all cases are among people in the prime of their lives.
July 22, 2021
by drugs
Could Menopausal Hormone Therapy Reduce Women's Odds for Dementia?
Women on hormone replacement therapy (HRT) for menopause go on to have a 58% lower risk of Alzheimer's disease and other neurodegenerative conditions, a new study finds.
July 21, 2021
by drugs
New Prescribing Instructions Tighten Use of Controversial Alzheimer's Drug
The U.S. Food and Drug Administration on Thursday issued new prescribing rules for the controversial Alzheimer's medication Aduhelm that will likely limit its use.
July 9, 2021
by drugs
Tipping the scales - Aduhelm’s hefty price under the spotlight
Biogen’s Alzheimer’s drug Aduhelm has recently secured FDA approval to much fanfare.
July 7, 2021
by cphi-online
House Committees to Investigate New Alzheimer Disease Drug Approval
The U.S. Food and Drug Administration's controversial approval of a new drug for Alzheimer disease, along with its high price, is now being investigated by two House committees.
July 2, 2021
by drugs